| Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment PN Lara Jr, R Higdon, N Lim, K Kwan, M Tanaka, DHM Lau, T Wun, ... Journal of clinical oncology 19 (6), 1728-1733, 2001 | 633 | 2001 |
| Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma PH Wiernik, IS Lossos, JM Tuscano, G Justice, JM Vose, CE Cole, W Lam, ... Journal of Clinical Oncology 26 (30), 4952-4957, 2008 | 487 | 2008 |
| CD22, A B LYMPHOCYTE–SPECIFIC ADHESION MOLECULE THAT REGULATES ANTIGEN RECEPTOR SIGNALING* TF Tedder, J Tuscano, S Sato, JH Kehrl Annual review of immunology 15 (1), 481-504, 1997 | 391 | 1997 |
| Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated … LI Gordon, F Hong, RI Fisher, NL Bartlett, JM Connors, RD Gascoyne, ... Journal of Clinical Oncology 31 (6), 684, 2013 | 335 | 2013 |
| Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma TM Habermann, IS Lossos, G Justice, JM Vose, PH Wiernik, K McBride, ... British journal of haematology 145 (3), 344-349, 2009 | 297 | 2009 |
| Nondestructive identification of individual leukemia cells by laser trapping Raman spectroscopy JW Chan, DS Taylor, SM Lane, T Zwerdling, J Tuscano, T Huser Analytical chemistry 80 (6), 2180-2187, 2008 | 234 | 2008 |
| Diagnosis and classification of autoimmune hemolytic anemia GF Bass, ET Tuscano, JM Tuscano Autoimmunity reviews 13 (4-5), 560-564, 2014 | 190 | 2014 |
| Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003) MV Dhodapkar, JL Jacobson, MA Gertz, SE Rivkin, GD Roodman, ... Blood, The Journal of the American Society of Hematology 98 (1), 41-48, 2001 | 174 | 2001 |
| Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma T Wun, H McKnight, JM Tuscano Leukemia research 28 (2), 179-190, 2004 | 163 | 2004 |
| Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research KS Lam, R Liu, S Miyamoto, AL Lehman, JM Tuscano Accounts of chemical research 36 (6), 370-377, 2003 | 139 | 2003 |
| Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center JM Tuscano, KM Druey, A Riva, J Pena, CB Thompson, JH Kehrl | 133 | 1996 |
| CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor S Sato, JM Tuscano, M Inaoki, TF Tedder Seminars in immunology 10 (4), 287-297, 1998 | 128 | 1998 |
| Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double‐blind placebo‐controlled trial SE Wang, PN Lara Jr, A Lee‐Ow, J Reed, LR Wang, P Palmer, ... American journal of hematology 70 (3), 191-194, 2002 | 116 | 2002 |
| Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment. J Higashida, T Wun, S Schmidt, SM Naguwa, JM Tuscano The Journal of Rheumatology 32 (11), 2109-2115, 2005 | 114 | 2005 |
| NCCN guidelines® insights: B-cell lymphomas, version 5.2021: featured updates to the NCCN guidelines AD Zelenetz, LI Gordon, JE Chang, B Christian, JS Abramson, RH Advani, ... Journal of the National Comprehensive Cancer Network 19 (11), 1218-1230, 2021 | 112 | 2021 |
| Regulation of JAK3 expression and activation in human B cells and B cell malignancies. PJ Tortolani, BK Lal, A Riva, JA Johnston, YQ Chen, GH Reaman, ... Journal of immunology (Baltimore, Md.: 1950) 155 (11), 5220-5226, 1995 | 111 | 1995 |
| B‐cell depletion with anti‐CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor‐β receptor II dominant negative mice Y Moritoki, ZX Lian, K Lindor, J Tuscano, K Tsuneyama, W Zhang, Y Ueno, ... Hepatology 50 (6), 1893-1903, 2009 | 106 | 2009 |
| Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation J Tuscano, P Engel, TF Tedder, JH Kehrl | 105 | 1996 |
| CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade JM Tuscano, A Riva, SN Toscano, TF Tedder, JH Kehrl Blood, The Journal of the American Society of Hematology 94 (4), 1382-1392, 1999 | 104 | 1999 |
| A novel human homeobox gene distantly related to proboscipedia is expressed in lymphoid and pancreatic tissues. KA Harrison, KM Druey, Y Deguchi, JM Tuscano, JH Kehrl Journal of Biological Chemistry 269 (31), 19968-19975, 1994 | 100 | 1994 |
